These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25765509)

  • 1. Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied.
    Roberts DW; Api AM; Safford RJ; Lalko JF
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):683-93. PubMed ID: 25765509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extension of the Dermal Sensitisation Threshold (DST) approach to incorporate chemicals classified as reactive.
    Safford RJ; Api AM; Roberts DW; Lalko JF
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):694-701. PubMed ID: 25934255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinement of the Dermal Sensitisation Threshold (DST) approach using a larger dataset and incorporating mechanistic chemistry domains.
    Safford RJ; Aptula AO; Gilmour N
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):218-24. PubMed ID: 21447365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dermal Sensitisation Threshold- a TTC approach for allergic contact dermatitis.
    Safford RJ
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):195-200. PubMed ID: 18406502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating the Dermal Sensitisation Thresholds using an expanded dataset and an in silico expert system.
    Chilton ML; Api AM; Foster RS; Gerberick GF; Lavelle M; Macmillan DS; Na M; O'Brien D; O'Leary-Steele C; Patel M; Ponting DJ; Roberts DW; Safford RJ; Tennant RE
    Regul Toxicol Pharmacol; 2022 Aug; 133():105200. PubMed ID: 35662638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the dermal sensitization threshold concept to chemicals classified as high potency category for skin sensitization assessment of ingredients for consumer products.
    Nishijo T; Api AM; Gerberick GF; Miyazawa M; Roberts DW; Safford RJ; Sakaguchi H
    Regul Toxicol Pharmacol; 2020 Nov; 117():104732. PubMed ID: 32795584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the skin sensitising potency of the lower alkyl methacrylate esters.
    Kimber I; Pemberton MA
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):24-36. PubMed ID: 24956587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
    Roberts DW; Api AM; Aptula AO
    Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A future approach to measuring relative skin sensitising potency: a proposal.
    Jowsey IR; Basketter DA; Westmoreland C; Kimber I
    J Appl Toxicol; 2006; 26(4):341-50. PubMed ID: 16773645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin sensitisation, vehicle effects and the local lymph node assay.
    Basketter DA; Gerberick GF; Kimber I
    Food Chem Toxicol; 2001 Jun; 39(6):621-7. PubMed ID: 11346493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
    Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a dermal sensitization threshold (DST) concept for risk assessment: structure-based DST and
    Nishijo T; Api AM; Gerberick GF; Miyazawa M; Na M; Sakaguchi H
    Crit Rev Toxicol; 2022 Jan; 52(1):51-65. PubMed ID: 35416118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?
    Roberts DW; Schultz TW; Api AM
    Regul Toxicol Pharmacol; 2016 Oct; 80():260-7. PubMed ID: 27477089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of contact allergens according to potency: proposals.
    Kimber I; Basketter DA; Butler M; Gamer A; Garrigue JL; Gerberick GF; Newsome C; Steiling W; Vohr HW
    Food Chem Toxicol; 2003 Dec; 41(12):1799-809. PubMed ID: 14563405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
    Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
    Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of guinea pig data to obtain starting points for skin sensitisation risk assessment - A commentary.
    Basketter D; Corea N; Corvaro M; Grivel A; Kluxen FM; Morgan N; Wiemann C
    Regul Toxicol Pharmacol; 2024 Mar; 148():105584. PubMed ID: 38417477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of the local lymph node assay (LLNA) for skin sensitisation.
    Roberts DW; Kimber I; Basketter DA
    Regul Toxicol Pharmacol; 2023 Jun; 141():105402. PubMed ID: 37116738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation.
    Basketter D; Poole A; Kimber I
    Regul Toxicol Pharmacol; 2017 Jun; 86():101-106. PubMed ID: 28274809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
    Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.